Literature DB >> 20146582

Insulinoma: pathophysiology, localization and management.

Joyce J Shin1, Phillip Gorden, Steven K Libutti.   

Abstract

Insulinoma is a rare neuroendocrine tumor that causes oversecretion of insulin and, as a result, patients present with symptoms of hypoglycemia. Fortunately, insulinomas are usually benign and solitary, and surgical cure rates are highly favorable. Most of these tumors occur sporadically, but they can also be associated with multiple endocrine neoplasia type-1 syndrome. The diagnosis is confirmed by a supervised fast, and early detection is important. Several preoperative and intraoperative techniques with various success rates have been employed in order to localize the lesion. When technically feasible, tumor enucleation is the procedure of choice; however, a more formal resection may be necessary for certain tumors. In the age of laparoscopy, the role of laparoscopic surgery in the management of insulinomas is continuing to attract attention. This review will discuss the historical background, pathogenesis, diagnosis, localization and management of insulinomas.

Entities:  

Mesh:

Year:  2010        PMID: 20146582      PMCID: PMC3498768          DOI: 10.2217/fon.09.165

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  84 in total

1.  Suppression of hypoglycemic attacks and insulin release by propranolol in a patient with metastatic malignant insulinoma.

Authors:  M Shaklai; D Aderka; I Blum; Z Laron; J Asherov; M Doron; A Atsmon; J Pinkhas
Journal:  Diabete Metab       Date:  1977-09

2.  Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.

Authors:  S S Fajans; J C Floyd; C A Thiffault; R F Knopf; T S Harrison; J W Conn
Journal:  Ann N Y Acad Sci       Date:  1968-04-11       Impact factor: 5.691

Review 3.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 4.  Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.

Authors:  P N Maton; J D Gardner; R T Jensen
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

5.  Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?

Authors:  C D Stehouwer; W F Lems; H R Fischer; W H Hackeng
Journal:  Neth J Med       Date:  1989-08       Impact factor: 1.422

6.  Aggressive surgery for metastatic liver neuroendocrine tumors.

Authors:  Jeffrey A Norton; Robert S Warren; Mary G Kelly; Marlene B Zuraek; Robert T Jensen
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Insulinoma. The value of intraoperative ultrasonography.

Authors:  C S Grant; J van Heerden; J W Charboneau; E M James; C C Reading
Journal:  Arch Surg       Date:  1988-07

9.  Pancreatic insulinomas.

Authors:  F Menegaux; G Schmitt; M Mercadier; J P Chigot
Journal:  Am J Surg       Date:  1993-02       Impact factor: 2.565

10.  Evidence for a therapeutic effect of dl-propranolol in benign and malignant insulinoma: report of three cases.

Authors:  I Blum; Y Rusecki; M Doron; M Lahav; Z Laron; A Atsmon
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

View more
  36 in total

Review 1.  The functioning side of the pancreas: a review on insulinomas.

Authors:  I Maggio; V Mollica; N Brighi; G Lamberti; L Manuzzi; A D Ricci; D Campana
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

2.  Paroxysmal Dystonia with Axonal Neuropathy Resulting from Benignant Insulinoma: Case Report.

Authors:  Nicolò Gabriele Pozzi; Roberto De Marzi; Roberta Zangaglia; Brigida Minafra; Claudio Pacchetti
Journal:  Mov Disord Clin Pract       Date:  2015-02-24

3.  Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.

Authors:  Sita D Modali; Vaishali I Parekh; Electron Kebebew; Sunita K Agarwal
Journal:  Mol Endocrinol       Date:  2015-01-07

4.  Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas.

Authors:  João Sérgio Neves; Luís Teles; Vanessa Guerreiro; Eva Lau; Ana Isabel Oliveira; Luís Graça; José Manuel Lopes; Paula Freitas; Davide Carvalho
Journal:  Endocrine       Date:  2020-10-17       Impact factor: 3.633

5.  Long Noncoding RNA MEG3 Is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells.

Authors:  Sucharitha Iyer; Sita D Modali; Sunita K Agarwal
Journal:  Mol Cell Biol       Date:  2017-10-27       Impact factor: 4.272

6.  Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.

Authors:  Z Hamze; C Vercherat; A Bernigaud-Lacheretz; W Bazzi; R Bonnavion; J Lu; A Calender; C Pouponnot; P Bertolino; C Roche; R Stein; J Y Scoazec; C X Zhang; M Cordier-Bussat
Journal:  Endocr Relat Cancer       Date:  2013-10-24       Impact factor: 5.678

7.  Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.

Authors:  Pavel Nockel; Bruna Babic; Corina Millo; Peter Herscovitch; Dhaval Patel; Naris Nilubol; Samira M Sadowski; Craig Cochran; Phillip Gorden; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

8.  Hypersomnia as the first presentation in a patient with insulinoma: A case report and review of the literature.

Authors:  Jiali Pu; Baorong Zhang; Xinzhen Yin
Journal:  Mol Clin Oncol       Date:  2016-07-27

9.  Insulinoma Due to Multiple Pancreatic Microadenoma Localized by Multimodal Imaging.

Authors:  Bruna Babic; Xavier Keutgen; Pavel Nockel; Markke Miettinen; Corina Millo; Peter Herscovitch; Dhaval Patel; Naris Nilubol; Craig Cochran; Phillip Gorden; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2016-08-09       Impact factor: 5.958

Review 10.  Pancreatic insulinomas: Laparoscopic management.

Authors:  Pantelis T Antonakis; Hutan Ashrafian; Alberto Martinez-Isla
Journal:  World J Gastrointest Endosc       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.